Curanex Pharmaceuticals Inc (CURX) Directors and Executive Officers - CSIMarket
CSIMarket
 
Curanex Pharmaceuticals Inc  (NASDAQ: CURX)

Curanex Pharmaceuticals Inc

Officers & Directors


Jun Liu serves as Chief Executive Officer and President under an employment agreement effective March 2, 2026, with an initial three-year term and an annual base salary of $393,600. The agreement includes non-disclosure, confidentiality, and non-solicitation provisions, as well as termination and severance terms. Dr. Liqin Xie is Chief Operating Officer under an employment agreement effective March 2, 2026, with an annual base salary of $180,000, eligibility for equity incentives, and participation in employee benefit plans. This agreement also contains non-disclosure, confidentiality, and non-solicitation provisions, along with termination and severance terms. Dr. Huijuan Zhong holds the position of Chief Scientific Officer, with an offer letter dated May 11, 2024. Following the IPO, Dr. Zhong received total compensation of $66,667 and was issued 24,000 shares of Common Stock on March 18, 2026.

Curanex Pharmaceuticals Inc currently has 6 employees.






CURX Management Effectiveness CURX Revenue per Employee CURX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.